Clinical trial IJB-LBC-NEOCHECKRAY-2018
Neo-adjuvant chemotherapy combined with SBRT to the primary tumor +/- durvalumab +/- oleclumab in luminal B breast cancer: a phase ll randomized trial
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2018-004165-13 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03875573 |
| Inclusion criteria | No contraindication for immunotherapy |
| Last update |